Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1187
https://www.valueinhealthjournal.com/article/S1098-3015(15)03263-5/fulltext
Title : Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03263-5&doi=10.1016/j.jval.2015.09.1187
First page : A460
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 686
Categories :
Tags :
Regions :
ViH Article Tags :